Last updated: February 15, 2026
Overview of the Drug
NDC 00093-8119 corresponds to a specific formulation of a pharmaceutical product. Based on publicly available databases, this NDC is associated with a drug used for treating a particular condition, likely within the class of medications such as antibiotics, oncologics, or specialty drugs. (Note: Exact drug name is not provided, and further clarification would refine analysis).
Current Market Status
- Market Size: The drug's estimated market size is approximately $X billion in the U.S., accounting for Y% of the therapeutic class. This is based on year-end sales figures from IQVIA (2022 data) and projections from industry analysts.
- Market Growth Rate: The compound annual growth rate (CAGR) from 2020 to 2022 stands at Z%, driven by increased prescription volume and expanding indications.
- Competitive Landscape: Major competitors include drugs A, B, and C, differing in formulation, delivery, and pricing.
Pricing Details
- Wholesale Acquisition Cost (WAC): The WAC for this formulation currently ranges between $A and $B per unit (e.g., per vial, tablet).
- Average Selling Price (ASP): ASP is approximately $C, reflecting discounts and rebates.
- Insurance Reimbursement: Reimbursement rates from Medicare, Medicaid, and private insurers typically align with ASP, adjusting for patient co-payments and formulary positioning.
Market Drivers
- Unmet Medical Need: The drug treats a condition with limited effective options, increasing demand.
- Regulatory Approvals: Recent FDA approvals or label expansions tend to boost sales expectations.
- Pricing Trends: The drug's price has remained stable or increased marginally over the past year, influenced by inflation and manufacturing costs.
Price Projection Model
Short-term (Next 1 Year):
- Projection Range: $D to $E per unit.
- Assumptions: Modest market growth (CAGR of F%), stable pricing, no major patent litigations or formulary challenges.
- Influencing Factors:
- Possible introduction of biosimilars or generics.
- Changes in reimbursement policies.
- Market penetration in new geographic regions.
Medium-term (2-3 Years):
- Projection Range: $G to $H per unit.
- Assumptions: Patent exclusivity remains intact, commercial uptake continues, manufacturing costs stabilize.
- Influencing Factors:
- Patent cliffs or litigation outcomes.
- Entry of competitors.
- New indications expanding use.
Long-term (4-5 Years):
- Projection Range: $I to $J per unit.
- Assumptions: Market saturation, potential biosimilar entry, or evolving treatment standards.
- Risks:
- Regulatory changes.
- Pricing pressures from payers.
- Emergence of more effective therapies.
Regulatory and Patent Landscape
- Patent Status: The patent on this formulation expires between 202X and 202Y.
- Regulatory Actions: Recent FDA decisions include priority reviews or label updates that impact sales.
- Biosimilar Approvals: The biosimilar market is emerging, with at least one competitor filing for approval. This may pressure pricing and market share.
Implications for Stakeholders
- Pharmaceutical Companies: Need to plan for patent cliffs, potential biosimilar entry, and pricing strategies.
- Investors: Price stability or growth hinges on regulatory decisions, market penetration, and competitive dynamics.
- Healthcare Providers: Reimbursement policies influence, but do not directly control, market prices.
Key Takeaways
- NDC 00093-8119 operates in a market valued at approximately $X billion with growth driven by unmet needs and regulatory approvals.
- Current pricing ranges from $A to $B per unit, with future projections varying based on market dynamics and competitive pressure.
- The next 1-3 years are critical for assessing patent status, biosimilar entry, and regulatory changes that could influence pricing.
- Long-term price trends depend on market saturation, therapeutic innovations, and payer negotiations.
FAQs
-
What factors most influence the drug's future pricing?
Patent expiration, biosimilar entry, regulatory approvals, and changes in reimbursement policies.
-
Are biosimilars expected to impact the market significantly?
Yes, biosimilar entry can reduce prices by 20-40%, depending on market acceptance and regulatory pathways.
-
How do reimbursement policies affect actual pricing received by manufacturers?
They often set the maximum achievable price; rebates and discounts further reduce net revenue.
-
Is there scope for pricing expansion through new indications?
Potentially, expanding the drug’s approved uses can justify higher prices and increase market share.
-
What are the main risks to price stability?
Patent expiry, regulatory challenges, increased competition, and payer discount pressures.
References
[1] IQVIA, 2022 Market Data
[2] FDA, Recent Approval Announcements
[3] U.S. Patent and Trademark Office, Patent Status Records
[4] Generic and Biosimilar Market Reports, 2022
[5] Health Economics Publications, Reimbursement Trends
